Aduhelm, a monoclonal antibody that targets amyloid-beta, is covered under Medicare for beneficiaries enrolled in clinical trials.

Looking at stress and university students during the COVID-19 pandemic.

New and improved to provide a more modern and readable format for the latest neurology news for today’s neurologists.

We spoke with Rebecca Edelmayer, PhD, the Alzheimer’s Association Senior Director of Scientific Engagement, about studies presented at the Alzheimer’s Association International Conference (AAIC) 2022 regarding individual’s life experiences and brain health.

The most common symptoms of monkeypox that have neurologic origins may also be related to infectious disease overall.

A biomarker for both ALS and FTD, 2 neurological disorders that share clinical, genetic, and pathological traits, can help signal disease onset and the progression of degeneration.

David Howell, PhD; and Heather Sesma, PhD; provide insight into the specific sequelae of concussion in youth and risk for subsequent mental health issues.

In addition to the physical risks, experts anticipate a myriad of mental health ramifications stemming from the loss of abortion access and the associated economic and occupational repercussions.

The main focus of the debate surrounding pediatric bipolar disorder pertains to the concept of a prepubertal subtype of the disorder.

Ines Moreno-Gonzalez, PhD, an adjunct associate professor of neurology, explains healthy aging can help reduce lifestyle risk factors for Alzheimer disease.